Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis

BACKGROUND: Given the controversial roles of FMS-like tyrosine kinase 3 inhibitors (FLT3i) in various treatment stages of acute myeloid leukemia (AML), this study was designed to assess this problem and further explored which FLT3i worked more effectively. METHODS: A systematic review, meta-analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Qingyu, He, Shujiao, Yu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209493/
https://www.ncbi.nlm.nih.gov/pubmed/34150652
http://dx.doi.org/10.3389/fonc.2021.686013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209493/
https://www.ncbi.nlm.nih.gov/pubmed/34150652
http://dx.doi.org/10.3389/fonc.2021.686013

Ejemplares similares